Buvidal Approved for Treatment of Opioid Dependence Subcutaneous injection once a week – Dec. 18, 2020 - Camurus AB (NASDAQ STO: CAMX) announced today that the Swiss agency for therapeutic products, Swissmedic, has approved weekly and monthly Buvidal® prolonged... Read More...Addiction RecoveryBooks, Memoirs, Films, and MediaDec 22 2020Drug Abuse and Addictionopioid crisisopioids